Today: 9 June 2026
Tesla stock price slides early as China AI training report and Europe sales warnings hit TSLA
6 February 2026
2 mins read

Tesla stock price slides early as China AI training report and Europe sales warnings hit TSLA

New York, Feb 6, 2026, 09:32 EST — Regular session

  • Tesla shares dipped in early New York trading as investors digested new headlines on China and AI.
  • Fresh European registration figures suggest increasing competition for the EV maker.
  • U.S. policymakers’ ongoing focus on self-driving regulations keeps autonomy squarely in play.

Tesla shares dropped 2.2% to $397.21 in early Friday trading, reacting to news of the company running an AI training center in China. The stock had closed at $406.32 the previous session.

Tesla’s pitch to investors hinges on more than just car sales. It places a strong bet on software and assisted-driving tech, with China standing as the fiercest arena for these battles.

The timing couldn’t be worse. Investors are already retreating from tech and growth stocks, grappling with which sectors AI will boost and which it will disrupt beyond repair.

Chinese media outlet Cailianshe reported Tesla has set up an AI training centre in China, concentrating on “local application and assisted driving,” according to Tesla Vice President Tao Lin. Reuters

Assisted driving, shorthand for advanced driver-assistance systems, involves software that aids with steering or speed control but still needs a human behind the wheel. For Tesla, even a slight acceleration in this area grabs more attention than a typical product update.

In Europe, the latest figures tell a different story. Volkswagen surpassed Tesla as the leading battery-electric vehicle (BEV) seller in 2025, delivering 274,278 BEVs compared to Tesla’s 236,357, according to JATO Dynamics. Tesla’s registrations dropped 27%, while VW’s climbed 56%, the data revealed.

UK sales numbers reveal the strain. Tesla’s deliveries tumbled over 57% in January, dropping to just 647 vehicles, according to New Automotive data. Meanwhile, Chinese competitor BYD sold 1,326 battery electric vehicles, a jump of nearly 21%. “British consumers are still moving towards cars with plugs, and away from those without,” said Tanya Sinclair, chief executive of Electric Vehicles UK. Reuters

Washington is pushing autonomy back into focus. This week, Tesla and Alphabet’s Waymo called on Congress to finally advance stalled legislation designed to accelerate self-driving car deployment, cautioning that the U.S. could lose ground to China. Tesla’s vehicle engineering VP Lars Moravy stressed that lawmakers “must modernize regulations that inhibit industry’s ability to innovate.” Reuters

Setting Tesla aside, growth stocks have taken a hit. Dave Harrison Smith, chief investment officer and head of technology investing at Bailard, called the retreat in U.S. software and data services shares a “sell-everything mindset” at work. Reuters

But Tesla’s risks remain clear: competition is heating up, regulators are setting the tempo for self-driving deployment, and legal challenges keep mounting. This week, a California judge ruled that a movie studio presented a “seemingly valid and plausible theory” of copyright infringement in a lawsuit over images used to promote Tesla’s autonomous cybercab. Reuters

Traders are turning their attention to key macro data that could shift rate expectations and impact pricey growth-stock valuations: the January U.S. nonfarm payrolls report, set for Wednesday (Feb. 11), followed by the consumer price index on Friday (Feb. 13).

Stock Market Today

  • U.S. Inflation Poised to Exceed 4% for First Time Since 2023, Pressures Mount on Fed
    June 9, 2026, 10:06 AM EDT. U.S. inflation is set to surpass 4% for the first time since 2023, signaling rising consumer prices and intensifying economic pressures. This uptick, measured by the year-over-year increase in the Consumer Price Index (CPI), highlights renewed challenges for the Federal Reserve (Fed) as it grapples with balancing inflation control against economic growth. The rise in inflation may influence the Fed's monetary policy decisions amid concerns over sustained price increases impacting households and businesses for the remainder of the year.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Ford stock slips before market open as EV sales dive and Geely talks linger
Previous Story

Ford stock slips before market open as EV sales dive and Geely talks linger

ServiceNow stock price slips as Wall Street sorts AI winners from losers
Next Story

ServiceNow stock price slips as Wall Street sorts AI winners from losers

Go toTop